Most of the alarming data about temperature rises as a result of likely climate change have come from high latitudes and altitudes. There appears growing evidence that glaciers and ice sheets are melting rapidly. The latest evidence comes from comparisons of pictures in the Andes reported last month which show that the Upsala glacier in Argentina has melted substantially, creating a lake where only ice previously occurred. But evidence of climate change at more temperate and lower latitudes has been more difficult to determine from the inter-annual variations.
So a new meta-analysis providing evidence that spring is arriving earlier across parts of Europe than it did 30 years ago, recently published in Global Change Biology, has attracted interest.
Researchers from 17 countries have collaborated in the world's largest phenology study, which records the changes in natural annual events, such as the flowering of plants, and now have real evidence that climate change is affecting the seasons. temperatures have also tended to delay autumn, by an average of about three days over the past 30 years.
News focus
Menzel said: "Unlike some studies that record individual species, this is the first comprehensive examination of all available data at the continental scale, using around 550 species, and the timing change is very clear."
Sparks said: "Not only do we clearly demonstrate change in the timing of seasons, but the change is much stronger in countries that have experienced more warming". He added: "Many plant species grow throughout Europe, so, for example, a direct comparison of the flowering date of wild cherry which is two weeks earlier in the UK with that in Austria which is only three days earlier is possible with this huge dataset."
But there have been some concerns raised about the new study. Meteorologist Philip Eden has written of his concern that the start point of the study was 1971, a particularly cold spring across much of Europe. "It is worrying that there was no acknowledgment, in the published abstract at least, that the start of the analysis period, 1971, sits in the middle of a period of abnormally cool springs over western, central and northern Europe, including the UK, which lasted from the early 1950s to the 1980s. "The spring of 1972, for instance, was so bad in Britain that many parts of the country failed to reach 21ºC that year until "The new work," wrote the Washington Post, "shows that even a single cell plucked from an early human embryo can be coaxed to divide repeatedly in a laboratory dish and grow into a colony of stem cells, coveted for their potential to mend failing organs."
The Post called it "an advance that could significantly reshape the ethical and political debates that have long entangled the research".
USA Today quoted Ronald Green, an ACT advisor who is also at Dartmouth: "It's not often that technology offers a solution to an ethical dilemma, but this could be one."
But the Gordian knot of embryo research is not so easily cut.
"The ethical difficulties with that are the eight-cell embryo could have become twins or triplets," Dr. Siobhan O'Sullivan from the Irish Council for Bioethics told the Irish Times. "Also you have no idea what difficulty you have made by taking away that one cell from the embryo. This is not going to sort out the ethical difficulties."
And, sure enough, the White House had a tepid response to this politically charged issue. It produced a widely quoted statement that read, in part: "The President is hopeful that with time scientists can find ways of deriving cells like those now derived from human embryos but without the need for using embryos."
One of the most outspoken US critics was Richard Doerflinger, at the Conference of Catholic Bishops. For example, he told the New York Times that the church objects to in vitro fertilization because, "divorcing procreation from the act of love made the embryo seem 'more of a product of manufacture than a gift'". Asked if he meant that the parents of a child conceived through in vitro fertilization would love it less, Mr. Doerflinger said he was referring to the clinic staff "... [who] may get more and more used to the idea of the child as manufacture".
Critics seized on one major weakness in the research: though the scientists showed that, in principle, they could extract a cell without destroying the embryo, in fact that's not what they did in this study. ACT started with 16 surplus embryos, but instead of extracting a single cell from each, the company extracted as many cells as they could -91, to be exact. Of those, just two were cultured into stem-cell lines. No embryos survived this particular experiment. The Financial Times seemed to miss this point, noting that ACT had generated stem-cell lines, "by plucking individual cells from newly fertilized human embryos, which are not harmed in the process".
As the Washington Post put it, the Nature paper, "includes a photo of a mature embryo, healthy and poised to grow into a fetus after having survived the removal of a single cell". Doerflinger said the photo is deceptive because no embryos in the experiment were allowed to develop that far. He said that was "reminiscent of the fraud Mediawatch: Richard F. Harris reports on press reaction to Advanced Cell Technology's latest work on human embryo cells.
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